The role of alpha-synuclein
Grand Challenges in Parkinson’s Disease: The Role of Alpha-Synuclein brought together hundreds of scientists, clinicians, people with Parkinson’s and caregivers to explore the latest in Parkinson’s disease research. This year’s theme focused on the role of alpha-synuclein in Parkinson’s—its function, its pathobiology, how it spreads and how studying it may lead to new biomarkers and therapies. Grand Challenges featured scientific presentations from 20 of the world’s leading experts on alpha-synuclein, along with poster and DataBlitz presentations. For the second year, VARI and The Cure Parkinson’s Trust hosted Rallying to the Challenge, a meeting for people with Parkinson’s, advocates and caregivers that explores how the Parkinson’s community can impact and accelerate research. Grand Challenges in Parkinson's Disease 2016 will take place Sept. 26-27, 2016 at Van Andel Research Institute.
Registration is now closed. For questions, please contact Kim Cousineau at Kim.Cousineau@vai.org.